ID   Sp2/0-Ag14
AC   CVCL_2199
SY   SP2/0-Ag14; SP2/0-AG14; SP2/0-ag14; Sp2/O-Ag14; SP2/O-Ag14; Sp2/0-Ag-14; SP2-0-Ag14; SP2/0 Ag-14; SP-2/0-AG14; Sp 2/0-Ag 14; Sp2/0; SP2/0; Sp2/O; SP2/O; SP-2; SP2; GM03569; GM3569; GM03569B; GM3569B; GM03569D
DR   BTO; BTO:0002291
DR   CLO; CLO_0009112
DR   CLO; CLO_0009113
DR   CLO; CLO_0009114
DR   CLO; CLO_0009115
DR   CLO; CLO_0017241
DR   CLO; CLO_0050178
DR   CLDB; cl4382
DR   CLDB; cl4383
DR   CLDB; cl4384
DR   CLDB; cl4385
DR   CLDB; cl4386
DR   AddexBio; C0033005/4967
DR   ATCC; CRL-1581
DR   ATCC; CRL-8287
DR   BCRC; 60034
DR   BCRJ; 0227
DR   BioSample; SAMN11397630
DR   CCRID; 1101MOU-PUMC000054
DR   CCRID; 1102MOU-NIFDC00011
DR   CCRID; 3101MOUTCM18
DR   CCRID; 3101MOUTCM42
DR   CCRID; 4201MOU-CCTCC00019
DR   CCRID; 5301MOU-KCB92021YJ
DR   CCRID; 6101MOU-CERC000118
DR   CCTCC; GDC0019
DR   CLS; 400481
DR   Coriell; GM03569
DR   DSMZ; ACC-146
DR   DSMZCellDive; ACC-146
DR   ECACC; 85072401
DR   IBRC; C10106
DR   JCRB; JCRB9084
DR   KCB; KCB 92021YJ
DR   KCLB; 21581
DR   Lonza; 329
DR   NCBI_Iran; C129
DR   RCB; RCB0209
DR   TKG; TKG 0248
DR   Wikidata; Q54955446
RX   CelloPub=CLPUB00447;
RX   PubMed=714156;
RX   PubMed=1373425;
RX   PubMed=6769123;
RX   PubMed=31220119;
CC   Group: Hybridoma fusion partner cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8287.
CC   Doubling time: ~30-40 hours (DSMZ=ACC-146).
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Misspelling: SP2/0-Ag15; Note=Occasionally.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 15,16,17
ST   Mouse STR 1-2: 16,17,19
ST   Mouse STR 11-2: 17,18
ST   Mouse STR 12-1: 15,16,17
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 16,17
ST   Mouse STR 18-3: 18,19
ST   Mouse STR 19-2: 12,13
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 21.3,22.3
ST   Mouse STR 5-5: 13,14
ST   Mouse STR 6-4: 17,18,19
ST   Mouse STR 6-7: 11,12
ST   Mouse STR 7-1: 26.2,28
ST   Mouse STR 8-1: 13
ST   Mouse STR X-1: 25
DI   NCIt; C125417; Mouse plasma cell myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 28
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   PubMed=714156; DOI=10.1038/276269a0;
RA   Shulman M., Wilde C.D., Kohler G.J.F.;
RT   "A better cell line for making hybridomas secreting specific
RT   antibodies.";
RL   Nature 276:269-270(1978).
//
RX   PubMed=1373425; DOI=10.1016/0022-1759(92)90173-q;
RA   Harris J.F., Hawley R.G., Hawley T.S., Crawford-Sharpe G.C.;
RT   "Increased frequency of both total and specific monoclonal antibody
RT   producing hybridomas using a fusion partner that constitutively
RT   expresses recombinant IL-6.";
RL   J. Immunol. Methods 148:199-207(1992).
//
RX   PubMed=6769123; DOI=10.1073/pnas.77.4.2197;
RA   Kohler G.J.F.;
RT   "Immunoglobulin chain loss in hybridoma lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 77:2197-2199(1980).
//
RX   PubMed=31220119; DOI=10.1371/journal.pone.0218412;
RA   Almeida J.L., Dakic A., Kindig K., Kone M., Letham D.L.D., Langdon S.,
RA   Peat R., Holding-Pillai J., Hall E.M., Ladd M., Shaffer M.D., Berg H.,
RA   Li J.-L., Wigger G., Lund S., Steffen C.R., Fransway B.B., Geraghty B.,
RA   Natoli M., Bauer B.A., Gollin S.M., Lewis D.W., Reid Y.A.;
RT   "Interlaboratory study to validate a STR profiling method for
RT   intraspecies identification of mouse cell lines.";
RL   PLoS ONE 14:E0218412-E0218412(2019).
//